FDA CDER appoints veteran GLP-1 reviewer Lisa Yanoff as acting deputy director

Acting FDA CDER director Michael Davis promoted Lisa Yanoff to the role of acting deputy director of the Center for Drug Evaluation and Research.

Yanoff is a long‑time FDA employee with deep expertise in reviewing metabolic therapies, especially GLP‑1 drugs.

The appointment underscores continuity in the agency’s oversight of the expanding GLP‑1 market and could affect upcoming review timelines.